Your session is about to expire
← Back to Search
Speech Therapy + tDCS for Aphasia
Study Summary
This trial aims to improve quality of life for people with PPA by combining speech-language telerehabilitation and tailored neuromodulatory treatment in their homes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My mental state score is 20 or higher.I don't have a history of seizures, head injuries, severe migraines, metal implants in my head, chronic skin problems, or a pacemaker. I am not pregnant.I have been diagnosed with primary progressive aphasia.I have been diagnosed with a specific type of primary progressive aphasia.You do not have the specific type of PPA that the study is focusing on.I can hear and see well enough, with aids if necessary.You have a score lower than 20 on a test that checks memory and thinking skills.My speech and language issues are due to a different neurological condition.I have had a stroke, epilepsy, or significant brain injury.I am willing and able to have an MRI scan of my brain.
- Group 1: RS-VISTA
- Group 2: RS-LRT
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Frequently Asked Questions
Is this experiment currently enrolling participants?
"Data from clinicaltrials.gov reveals that this medical study is currently seeking participants, and was initially posted on July 1st 2023 with the most recent update occurring on June 2nd of the same year."
How many individuals is the trial organization recruiting for participation?
"Affirmative. Clinicaltrials.gov lists this experiment as actively recruiting, with the initial posting dated July 1st 2023 and last update on June 2nd 2023. This investigation requires 10 participants from two separate medical sites."
What are the essential objectives of this medical experiment?
"The primary benchmark of success for this clinical trial is the change in script production accuracy between pre-treatment observations and those taken one month and three months after treatment begins. Additional metrics include shifts in Aphasia Impact Questionnaire scores, patient/client satisfaction as measured by a Client Satisfaction Questionnaire, and participants' perceptions regarding remote tdcs via an RS-tDCS Survey."
Share this study with friends
Copy Link
Messenger